ARTICLE | Company News
Shield Therapeutics sales and marketing update
June 27, 2016 7:00 AM UTC
Shield launched Feraccru ferric maltol in the U.K. to treat adults with iron deficiency anemia associated with inflammatory bowel disease (IBD). The price as agreed to with the U.K.’s Department of H...